Coherus Oncology, Inc. · NASDAQ:CHRS
BlackRock, Inc.'s stake in Coherus Oncology, Inc. fell to 4.90% (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc.'s stake in Coherus Oncology, Inc. fell to 4.90%, 7,337,261 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 7,337,261
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 4.90% | 7,337,261 |
Source
Related
- Coherus Oncology, Inc.
- BlackRock, Inc.
- Coherus Oncology, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 17, 2025
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Form 4 · Satvat Ali J. · Jun 9, 2026
- Form 4 · Karachun Rita A · Jun 9, 2026
- Form 4 · Newcomer Lee Nisley · Jun 9, 2026
- Form 4 · Ryan Michael Lee · Jun 9, 2026
- Form 4 · O'Donnell-Tormey Jill · Jun 9, 2026